MET and renal carcinoma: In this study, we report that HNK treatment significantly inhibits c-Met phosphorylation and c-Met-/CNI-induced Ras activation and HO-1-overexpression in renal cancer cells; and it restricts CNI-induced renal tumor growth in vivo.